Iranian
Biomedical Journal
Volume 29, Issue 4 (4-2025)
IBJ 2025, 29(4): 236-246 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahsavari S, Torabi P, Bohlooli S, Rezaie Shirmard L. Designing Oral Films Based on Beeswax: Comparative Assessment of 3D Printing and Solvent Casting. IBJ 2025; 29 (4) :236-246
URL: http://ibj.pasteur.ac.ir/article-1-5098-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5098-en.html
Abstract:
Background: From the perspective of DDSs, OFs have received increased attention, mainly for pediatric and geriatric applications. Beeswax, a naturally derived and FDA-approved material, is often mixed with other polymers to enhance its mechanical properties. This study presented the first use of precisely controlled, solvent-free pressure-assisted micro-syringe printing to produce OFs.
Methods: Solvent casting and pressure-assisted micro-syringe printing were employed to produce hybrid film structures composed of beeswax, PVA, borax, and HPMC, loaded with betamethasone as a model drug. The films were characterized based on their physical appearance, mechanical attributes, surface structure, and ultrastructure morphology via SEM, drug content, and in vitro drug release.
Results: Films without the drug showed greater irregularities and roughness compared to the drug-loaded films. The physical properties of the formulations improved through 3D printing.
Conclusion: By using 3D printing methods in pharmaceuticals, the treatment procedurewould be very acceptable to the patient and increases the patient's adherence to treatmentand is useful for personal drug delivery.
Methods: Solvent casting and pressure-assisted micro-syringe printing were employed to produce hybrid film structures composed of beeswax, PVA, borax, and HPMC, loaded with betamethasone as a model drug. The films were characterized based on their physical appearance, mechanical attributes, surface structure, and ultrastructure morphology via SEM, drug content, and in vitro drug release.
Results: Films without the drug showed greater irregularities and roughness compared to the drug-loaded films. The physical properties of the formulations improved through 3D printing.
Conclusion: By using 3D printing methods in pharmaceuticals, the treatment procedurewould be very acceptable to the patient and increases the patient's adherence to treatmentand is useful for personal drug delivery.
Type of Study: Full Length/Original Article |
Subject:
Pharmaceutical Biotechnology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |